Decentralized Clinical Trials – Whitepaper

03rd Sep 2020

Running decentralized clinical trials is complex. Especially when “85% of all clinical trials fail to recruit enough patients, 80% are delayed due to recruitment problems” (, 2019) and the COVID19 pandemic resulted in “almost 53.5% of clinical trials being suspended.” (Frost & Sullivan PB21-52 August 2020). We know it’s not about making the complex simple, it’s about making it happen efficiently and safely. To learn more read our whitepaper.

Back to the resources